Early Signs of M&A Activity Heating Up in 2023
By Lucy Haggerty
Pharma Deals Review: Vol 2023 Issue 1 (Table of Contents)
Published: 19 Jan-2023
DOI: 10.3833/pdr.v2023.i1.2758 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
After a relatively slow deal making year in 2022, there have been early signs that an uptick in business development activity could be seen in 2023...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018